WQ
NVAX icon

Wealth Quarterback’s Novavax NVAX Stock Holding History

Wealth Quarterback’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,986
Closed -$232K – 124
2023
Q3 		$232K Buy
+31,986
New +$256K 0.2% 93
2020
Q2 		– Sell
-200
Closed -$2.72K – 541
2020
Q1 		$2.72K Hold
200
– – ﹤0.01% 713
2019
Q4 		$796 Buy
+200
New +$867 ﹤0.01% 871

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wealth Quarterback's NVAX Position: Q4 2023 in Review

Wealth Quarterback sold out of Novavax (NVAX) in Q4 2023, closing a stake of 31,986 shares — an estimated $232K sold.

Wealth Quarterback first reported a position in NVAX in Q4 2019 and held it in 3 quarters. The position peaked at $232K in Q3 2023. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Wealth Quarterback reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • Wealth Quarterback sold 31,986 Novavax shares in Q4 2023, an estimated $232K.
  • Wealth Quarterback first reported a position in Novavax in Q4 2019 and held it in 3 quarters.
  • Wealth Quarterback's Novavax position peaked at $232K in Q3 2023.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Wealth Quarterback's 13F filing for Q4 2023, filed 13 Feb 2024.